Details for New Drug Application (NDA): 020771
✉ Email this page to a colleague
NDA 020771 describes DETROL, which is a drug marketed by Upjohn and is included in two NDAs. It is available from one supplier. Additional details are available on the DETROL profile page.
The generic ingredient in DETROL is tolterodine tartrate. There is one drug master file entry for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the tolterodine tartrate profile page.
The generic ingredient in DETROL is tolterodine tartrate. There is one drug master file entry for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the tolterodine tartrate profile page.
Summary for 020771
| Tradename: | DETROL |
| Applicant: | Upjohn |
| Ingredient: | tolterodine tartrate |
| Patents: | 0 |
Pharmacology for NDA: 020771
| Mechanism of Action | Cholinergic Muscarinic Antagonists |
Medical Subject Heading (MeSH) Categories for 020771
Suppliers and Packaging for NDA: 020771
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DETROL | tolterodine tartrate | TABLET;ORAL | 020771 | NDA | Viatris Specialty LLC | 58151-099 | 58151-099-91 | 60 TABLET, FILM COATED in 1 BOTTLE (58151-099-91) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
| Approval Date: | Mar 25, 1998 | TE: | AB | RLD: | Yes | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | Mar 25, 1998 | TE: | AB | RLD: | Yes | ||||
Complete Access Available with Subscription
